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One sentence summary   
Ribosomal frameshifting has not been reported to occur in human mitochondria, however, 
by the use of a bacterial endoribonuclease we show that this does indeed occur negating the 
apparent reassignment of AGA/AGG as stop codons. 
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Abstract   
Human mitochondria are not strict adherents to the universal genetic code with 
modifications that include the apparent recoding of 2 arginine triplets to termination 
signals. This use of both AGA and AGG occurs rarely in other mammals and the precise 
mechanism that has driven the change from encoding arginine to dictating a translational 
stop has posed a challenging conundrum. Sequence data reveals that a –1 frameshift of the 
mitoribosome upstream of the rare codons would necessitate the recognition of only the 
conventional UAA and UAG termination codons. With the use of a sequence specific 
endoribonuclease we show that the rare arginine codons presumably in association with 
other cis-elements do indeed promote frameshifting in human mitoribosomes. 
 
Following the sequencing of human mtDNA, it has been generally accepted that AGA and 
AGG have been recoded as stop signals (1). It was further assumed that an accommodation 
by mitochondrial release factor(s) must have occurred to ensure sequence specific 
recognition of these non-cognate stop codons (2). Closer inspection of the mt-genome 
sequence shows that the AGA/AGG codons that are predicted to terminate the 2 open 
reading frames, MTCO1 and MTND6 respectively, are both immediately downstream of a 
U residue. It is therefore possible that although these 2 codons do function in the terminal 
stage of translation, this role is primarily to stall the mitoribosome, causing a ribosomal 
frameshift on the human mt-mRNA. In contrast to any current mitochondrial examples this 
frameshift would be in the –1 direction and not in the protein coding region. Further, no 
modifications to release factors would need to have evolved. 
 
As a consequence of a -1 ribosomal frameshift, both of the open reading frames (ORFs) 
would terminate in the standard UAG codon and thereby follow the same ‘2 stop codon’ 
(UAA, UAG) mechanism common to many other mitochondrial gene expression systems 
(3). Frameshifting in either direction has never been reported in the expression of 
mammalian mtDNA, although limited examples of classical +1 Programmed Ribosome 
Frameshifting (PRF) have been postulated or documented in other species. The ostrich 
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nad3 gene, for example, was reported to encode only a truncated protein (4), but after 
examining sequences from a number of bird and turtle species, Mindell et al (5) noticed that 
only a single base insertion was responsible for the interruption of the ORF, resulting in a 
premature stop. It was, therefore, postulated that mitochondrial translation must invoke a 
+1 PRF. More recently, other studies have identified common single nucleotide insertions 
in the protein coding regions of a subset of mitochondrial genes from diverse species 
including oyster, glass sponge and ants (described in 6). All would require a similar +1 PRF 
for faithful production of the protein. It has led to the hypothesis that although rare, this +1 
PRF mechanism must be tolerated in specific mitochondrial translation systems from a 
wide range of organisms (6). The examples above described nucleic acid sequences that 
would predict the need for +1PRF to complete accurate mitochondrial protein synthesis. 
This contrasts with human mt-mRNA where all the coding sequences are known to be 
uninterrupted. However, we propose that human mitoribosomes do invoke –1 frameshift 
but at the stop codon after the proteins have been synthesised to completion, to allow 
recognition by the release factor and facilitate release of the nascent polypeptide. 
 
Is -1 ribosomal frameshifting supported by analysis of human mt-mRNA ? Particular 
features that promote classical frameshifting have been well characterised in other 
translation systems. One of the most commonly conserved is a ribosome that has paused or 
stalled as a consequence of either a rare or slowly decoded codon, or an inhibitory 
secondary structure (7-9). Precisely such paused mitoribosomes would be generated on 
human mt-mRNA by both AGA and AGG triplets, as no mt-tRNAs exist that recognize 
these codons. Further, these identical rare codons behave as ‘hungry codons’ in other 
translational systems under conditions of arginine deficiency, triggering a pause in 
translation and stimulating a –1 frameshift (8, 9). 
 
Two further common features that promote -1 frameshifting are an upstream heptapeptide 
‘slippery sequence’ and a downstream sequence that can generate a stable secondary 
structure such as a stem loop or pseudoknot (7). These features in the context of human 
mitochondrial MTCO1 and MTND6 transcripts are discussed below (Fig 1). 
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The upstream slippery sequence has been best characterised in viruses where the -1 
frameshift is a commonly used mechanism. The heptanucleotide consensus is X XXY YYZ 
(10), however a large number of functional variations to this have been documented 
(described in 11). Since the mammalian 55S mitoribosome differs in a number of ways 
from the bacterial 70S and eukaryotic 80S counterparts (12), the requirement for, position 
and the characteristics of a slippery sequence may be different. In particular it is important 
to note that the A, P and E-site tRNAs are all reported to be involved in viral PRF (13). 
However, no conventional E site is believed to exist in mitoribosomes (12), reducing both 
the number and hence overall strength of codon/anticodon interactions. Further, as human 
mitochondrial translation uses only 22 mt-tRNAs to recognize 60 codons, mt-tRNAs 
generate a looser codon:anticodon interaction than other systems by using a “2 out of 3” 
base interaction (14). Finally, when the A-site is occupied by an AGA or AGG codon there 
will be no corresponding mt-tRNA. Therefore, in contrast with conventional -1PRF, only a 
weak mt-mRNA/mt-tRNA interaction will need to be broken to allow reformation in the -1 
frame. 
 
With respect to the downstream element, it has been reported that such features act as 
positive modulators to significantly improve efficiency of poor heptanucleotide sequences 
(15). Although human mtDNA is remarkably concise and the derived transcripts are often 
depicted as having no untranslated regions, this is not entirely correct. In the case of 
MTCO1 the putative terminal AGA is followed by the antisense of tRNAser (UCN) that is 
generally not cleaved on processing (16). Similarly, the AGG of MTND6 is followed by 
UTRs of various lengths that extend into the antisense of MTND5 (16). Using folding 
algorithms (17), the antisense tRNAser (UCN) is predicted to generate a stable cloverleaf 
similar to a tRNA, and the sequence immediately downstream of MTND6 is predicted to 
form a stem loop (Fig 1). This bioinformatic data supports the hypothesis that MTCO1 and 
MTND6 transcripts contain features that can promote a -1 frameshift. 
 
 - 5 - 
Can -1 frameshifting be demonstrated on human mtRNA? To experimentally determine 
whether –1 frameshifting occurs in human mitochondria, we attempted to fine map the 
precise sequence of the MTCO1 termination codon. For this we constructed a 
mitochondrially targeted version of RelE (mtRelE, 18), an endoribonuclease that has 
previously been shown to specifically cleave RNA occupying the A site of the bacterial 
ribosome. Further, this enzyme shows marked sequence preference for the standard 
termination codons UAG and UAA. Human HEK293T cells were prepared to inducibly 
express mtRelE (18), which was efficiently localised and imported into the mitochondrial 
matrix as evidenced by protection from protease digestion after removal of the outer 
mitochondrial membrane (Fig S1). 
 
RelE has very distinct sequence selectivity; UAG is the preferred substrate, followed by 
UAA, with negligible predicted recognition of AGA/AGG and non detectable Kcat/Km 
values for AGA (18). This would infer that production of COX1 and ND6 whose ORFs 
putatively terminate in AGA/AGG should be unaffected. Global effects on mitochondrial 
translation were, therefore, assessed by metabolic labelling (S35-met) of wildtype and 
mtRelE induced cells (19). Strikingly, however, de novo synthesis of most mt-proteins 
including COX1 and ND6 was robustly reduced (Fig2A). Northern analysis of control cells 
post mtRelE expression revealed the majority of MTCO1 (68 ± 1.73 %, n=3) and MTCO2 
(70 ± 1.4 %, n=3) transcripts to be intact at steady state (Fig2B lanes 1 and 3). Hence, the 
loss of de novo protein synthesis could not be attributed to non-specific degradation of 
transcripts by mtRelE. Depletion of the endogenous mitochondrial release factor mtRF1a, 
is known to stabilise transcripts possibly through an extended association of the mt-mRNA 
with the mitoribosome. RelE expression promotes release of cleaved mRNA from the 
bacterial ribosome (18). Therefore, mtRelE expression would be predicted to release 
cleaved transcripts from the mitoribosome abrogating mitoribosome mediated protection. 
As shown in Fig2B mtRF1a depletion in tandem with mtRelE expression does indeed 
relieve such protection of all mt-transcripts analysed and markedly so for MTCO1 (Fig2B 
lanes 2 and 4) where the steady state level is reduced post mtRelE expression, indicating 
both recognition and cleavage by mtRelE. Northern analysis, could not resolve whether the 
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short 3’ UTRs present in MTCO1 (72 nt) had been lost post mtRelE cleavage. MTND5, 
however, possesses a more extensive 3’ UTR (568nt). On mtRelE induction, a species was 
detected with increased mobility consistent with cleavage at the stop codon and loss of this 
3’UTR (Fig2B lanes 3-4 indicated by *). Human mtDNA encodes 2 transcripts with 
overlapping open reading frames encoding MTATP8/6 (RNA14) and MTND4L/4 (RNA7). 
Cleavage at the stop codon of the upstream ORF would release an mRNA with a 5’-
truncated downstream ORF. As with MTND5, novel species were detected on mtRelE 
expression. This was particularly apparent for RNA14 where MTATP8 terminates in UAG, 
the preferred stop codon for RelE (Fig2B). 
 
To initiate the fine mapping of the mtRelE cleavage site in mt-mRNAs we first analysed 
MTCO2 as it terminates in the preferred UAG and would be predicted to lose its short (25 
nt) 3’UTR on mtRelE cleavage. Analysis by tail length assay indicated full-length 
polyadenylated transcripts in wildtype cells (Fig2C lanes 1-4). Processing of L-strand 
transcript 3’ termini in vivo normally leads to oligo- or polyadenylation (20). Consistent 
with this, a second population of shorter species of a length approximating to readenylated 
truncated transcripts, became evident post mtRelE induction (Fig2C lanes 5-8). To reveal 
the cleavage site, truncated species were sequenced after ligation mediated RT-PCR (LM 
RT-PCR, 19) and subsequent cloning. All sequences confirmed specific removal of the 
3’UTR followed by readenylation (Fig2C). However, since MTCO2 uses UAG as a stop 
codon, cleavage between either positions 1/2 or 2/3 within the codon would generate 
UAAAn, making it impossible to identify whether cleavage had occurred after nucleotide 1 
or 2. The same problem would be encountered with the UAA codons, which constitute 9 of 
the 13 termination codons in human mitochondria.   
 
To resolve the issue of positional cleavage within the triplet we examined RNA14 the 
bicistronic unit with overlapping ORFs, reasoning that cleavage of the upstream MTATP8 
UAG codon would release a stable downstream cleavage product. By mapping the 5’ 
termini of this species the precise mtRelE cleavage position would be revealed. Northern 
analysis indicated that post mtRelE induction greater than 90% of the remaining MTRNA14 
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was cleaved, resulting in mobility consistent with selective removal of MTATP8 (Fig2B). 
LM RT-PCR mediated cloning of the RNA species (FigS2) demonstrated a limited number 
of full-length RNA14, consistent with the Northern data. Crucially, however, all of the 
shortened species corresponded to specific mtRelE digestion at the UAG termination codon 
and cleavage only occurred between positions 2 and 3 (Fig3). 
 
Mitochondrially targeted RelE, therefore, displays A-site specificity for UAG and UAA 
termination codons and cleaves only between nucleotides 2 and 3 of the codon. Taken 
together this suggests that the loss of protein synthesis of COX1 and presumably ND6 is a 
result of both open reading frames terminating in UAG and not AGA/AGG respectively. 
However, to finally confirm that MTCO1 uses UAG and not AGA as a termination codon, 
we cloned and sequenced LM RT-PCR generated products of MTCO1 post-cleavage. As 
mtRelE cleaves only between the 2nd and 3rd nucleotides of the stop codon, a prediction can 
be made following mtRelE expression ;  use of AGA as termination codon would result in 
–AAAAUCUAGAn whilst UAG would produce –AAAAUCUAAn. RNA from control 
cells was analysed, 10 of the 12 clones reflected the predicted full-length MTCO1 transcript 
containing the 3’UTR, the remaining 2 were partial truncations in the antisense tRNA Ser, 
commonly identified in the EST database. This species was also found in 2 of the mtRelE 
samples. All of the remaining 33 mtRelE clones however, terminated in -AAAAUCUA 
followed by readenylation (Fig3B), signifying that MTCO1 terminates at UAG rather than 
AGA. 
 
In conclusion, human mitochondria invoke -1 frameshifting. This is facilitated by 
mitoribosomes stalling at AGA/AGG codons for which there are no cognate mt-tRNAs, 
potentially in concert with diminished upstream codon/anticodon interactions due to a non-
conventional E-site, and a secondary structure immediately downstream. In the absence of 
methods by which mammalian mitochondria can be transfected the contribution of these 5’ 
and 3’ elements cannot be interrogated. We have however, used a mitochondrially targeted 
endoribonuclease, mtRelE to confirm a mitoribosome shuffle that shunts the AGA/AGG 
from the A-site replacing them with the conventional stop codon, UAG. Perhaps 
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mitoribosomal shuffling could resolve the conundrum of translation initiation in the 
overlapping bicistronic transcripts ? 
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Figure legends 
Fig.1. Features that promote –1 frameshifting. 
Panel A depicts a cartoon of the characterised elements that promote PRF; an upstream 
slippery sequence (10, 11), a rare ‘hungry’ codon (8, 9) and a stable secondary structure 
downstream (12). Variations on these elements are present in mitochondrial transcripts 
MTCO1 (B) and MTND6 (C) (see text). 
 
Fig.2. Expression of mtRelE results in specific cleavage of mt-mRNA stop codons. 
Cells expressing mtRelE show:- (A) reduced metabolic labelling of mtDNA encoded gene 
products ; (B) specific cleavage of mt-mRNA generating novel products depicted by * in 
both wild type cells and those treated with siRNA to mtRF1a ; and (C) stop codon 
selectivity, as shown here for MTCO2 where cleavage removes the short 3’UTR prior to 
readenylation (lower panel). 
 
Fig.3. Sequence analysis of RNA14 and MTCO1 transcripts post mtRelE expression. 
A. RNA14 sequence across the MTATP8/6 overlap indicates the respective stop and start 
codons. Post LM-PCR and cloning CACAT would precede the 5’ terminal sequence of 
MTATP6, which upon cleavage by mtRelE between nucleotide position 2 and 3 would start 
GGCC. A representative electropherogram of RNA14 derived transcripts post mtRelE 
expression is shown. All of the mtRelE clones analysed indicated cleavage had occurred 
ONLY between 2nd and 3rd nucleotides (A and G). 
B. Representative electropherogram of MTCO1 derived transcripts from wild type (WT) 
cells and post mtRelE expression. Sequences are given below with the mtRelE cleavage site 
designated by *. WT has retained the 3’UTR whilst 33/35 mtRelE demonstrated loss of the 
3’UTR (lower panel), consistent with cleavage at the UAG stop codon. The remaining 2 
clones showed truncated WT sequences identified in EST databases. 
 
